Vcanbio Cell & Gene Engineering Corp Ltd (600645) — Strategic Asset Allocation Index
Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Strategic Asset Allocation Index of 19.8% as of June 2023. Strategic assets (PP&E of CN¥747.42 Million plus long-term investments of CN¥-) total CN¥747.42 Million, measured against net assets of CN¥3.78 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Vcanbio Cell & Gene Engineering Corp Ltd net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Vcanbio Cell & Gene Engineering Corp Ltd Strategic Asset Allocation Index (2000–2021)
This chart shows how Vcanbio Cell & Gene Engineering Corp Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of June 2023, the index stands at 19.8%, representing strategic assets of CN¥747.42 Million against net assets of CN¥3.78 Billion CNY. For live market cap and overall valuation, see Vcanbio Cell & Gene Engineering Corp Ltd market capitalisation.
Annual Strategic Asset Allocation Index for Vcanbio Cell & Gene Engineering Corp Ltd (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Vcanbio Cell & Gene Engineering Corp Ltd from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Vcanbio Cell & Gene Engineering Corp Ltd book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 21.7% | CN¥766.09 Million | CN¥766.09 Million | CN¥- | CN¥3.53 Billion | ▲ +0.7 pp |
| 2020 | 20.9% | CN¥733.46 Million | CN¥733.46 Million | CN¥- | CN¥3.50 Billion | ▼ -0.9 pp |
| 2019 | 21.8% | CN¥755.44 Million | CN¥755.44 Million | CN¥- | CN¥3.46 Billion | ▼ -21.2 pp |
| 2018 | 43.0% | CN¥1.28 Billion | CN¥722.67 Million | CN¥562.09 Million | CN¥2.98 Billion | ▼ -34.6 pp |
| 2017 | 77.6% | CN¥1.27 Billion | CN¥789.30 Million | CN¥479.03 Million | CN¥1.63 Billion | ▲ +11.3 pp |
| 2016 | 66.3% | CN¥1.16 Billion | CN¥771.87 Million | CN¥388.88 Million | CN¥1.75 Billion | ▲ +8.3 pp |
| 2015 | 57.9% | CN¥974.44 Million | CN¥591.25 Million | CN¥383.19 Million | CN¥1.68 Billion | ▲ +29.2 pp |
| 2014 | 28.7% | CN¥332.18 Million | CN¥332.18 Million | CN¥- | CN¥1.16 Billion | ▼ -11.2 pp |
| 2013 | 39.9% | CN¥263.44 Million | CN¥263.44 Million | CN¥- | CN¥660.07 Million | ▼ -43.4 pp |
| 2012 | 83.3% | CN¥234.61 Million | CN¥234.61 Million | CN¥- | CN¥281.54 Million | ▲ +25.7 pp |
| 2011 | 57.6% | CN¥154.83 Million | CN¥154.83 Million | CN¥- | CN¥268.85 Million | ▼ -9.1 pp |
| 2010 | 66.7% | CN¥162.90 Million | CN¥162.90 Million | CN¥- | CN¥244.13 Million | ▼ -16.4 pp |
| 2009 | 83.1% | CN¥198.76 Million | CN¥198.76 Million | CN¥- | CN¥239.23 Million | ▲ +12.7 pp |
| 2008 | 70.4% | CN¥180.48 Million | CN¥180.48 Million | CN¥- | CN¥256.31 Million | ▼ -59.1 pp |
| 2007 | 129.5% | CN¥240.16 Million | CN¥240.16 Million | CN¥- | CN¥185.42 Million | ▼ -10.8 pp |
| 2006 | 140.3% | CN¥258.18 Million | CN¥258.18 Million | CN¥- | CN¥184.04 Million | ▲ +22.3 pp |
| 2005 | 117.9% | CN¥194.54 Million | CN¥194.54 Million | CN¥- | CN¥164.95 Million | ▲ +67.2 pp |
| 2004 | 50.7% | CN¥157.19 Million | CN¥157.19 Million | CN¥- | CN¥309.95 Million | ▲ +13.7 pp |
| 2003 | 37.0% | CN¥135.15 Million | CN¥135.15 Million | CN¥- | CN¥365.02 Million | ▲ +6.2 pp |
| 2002 | 30.9% | CN¥110.41 Million | CN¥110.41 Million | CN¥- | CN¥357.83 Million | ▲ +2.6 pp |
| 2001 | 28.3% | CN¥117.04 Million | CN¥117.04 Million | CN¥- | CN¥414.06 Million | ▼ -1.1 pp |
| 2000 | 29.4% | CN¥127.50 Million | CN¥127.50 Million | CN¥- | CN¥433.95 Million | — |